PDF herunterladen
Semin Plast Surg 2021; 35(03): 153-158
DOI: 10.1055/s-0041-1731460
Review Article

Updates in Diabetic Wound Healing, Inflammation, and Scarring

Nina Dasari
1   Division of Plastic Surgery, Department of Surgery, Baylor College of Medicine, Houston, Texas
,
Austin Jiang
1   Division of Plastic Surgery, Department of Surgery, Baylor College of Medicine, Houston, Texas
,
Anna Skochdopole
1   Division of Plastic Surgery, Department of Surgery, Baylor College of Medicine, Houston, Texas
,
Jayer Chung
2   Division of Vascular Surgery, Department of Surgery, Baylor College of Medicine, Houston, Texas
,
Edward M. Reece
1   Division of Plastic Surgery, Department of Surgery, Baylor College of Medicine, Houston, Texas
3   Division of Plastic Surgery, Department of Surgery, Texas Children's Hospital, Houston, Texas
,
Joshua Vorstenbosch
4   Division of Plastic Surgery, Department of Surgery, McGill University, Montreal, Canada
,
Sebastian Winocour
1   Division of Plastic Surgery, Department of Surgery, Baylor College of Medicine, Houston, Texas
› Institutsangaben
› Weitere Informationen
    Lizenzen und Reprints

Abstract

Diabetic patients can sustain wounds either as a sequelae of their disease process or postoperatively. Wound healing is a complex process that proceeds through phases of inflammation, proliferation, and remodeling. Diabetes results in several pathological changes that impair almost all of these healing processes. Diabetic wounds are often characterized by excessive inflammation and reduced angiogenesis. Due to these changes, diabetic patients are at a higher risk for postoperative wound healing complications. There is significant evidence in the literature that diabetic patients are at a higher risk for increased wound infections, wound dehiscence, and pathological scarring. Factors such as nutritional status and glycemic control also significantly influence diabetic wound outcomes. There are a variety of treatments available for addressing diabetic wounds.

Keywords

diabetes - wound healing - inflammation - scarring


Publikationsverlauf

Artikel online veröffentlicht:
15. Juli 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Division of Diabetes Translation At A Glance | CDC. Published August 24, 2020. Accessed May 2, 2021 at: https://www.cdc.gov/chronicdisease/resources/publications/aag/diabetes.htm.
    PubMedGoogle Scholar
  • 2 Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005; 293 (02) 217-228
    CrossrefPubMedGoogle Scholar
  • 3 Driver VR, Fabbi M, Lavery LA, Gibbons G. The costs of diabetic foot: the economic case for the limb salvage team. J Vasc Surg 2010; 52 (3, Suppl): 17S-22S
    CrossrefPubMedGoogle Scholar
  • 4 Gorecka J, Kostiuk V, Fereydooni A. et al. The potential and limitations of induced pluripotent stem cells to achieve wound healing. Stem Cell Res Ther 2019; 10 (01) 87
    CrossrefPubMedGoogle Scholar
  • 5 Okonkwo UA, DiPietro LA. Diabetes and wound angiogenesis. Int J Mol Sci 2017; 18 (07) 1419
    CrossrefPubMedGoogle Scholar
  • 6 Wallace HA, Basehore BM, Zito PM. Wound Healing Phases. In: StatPearls. StatPearls Publishing; 2021. Accessed April 25, 2021 at: http://www.ncbi.nlm.nih.gov/books/NBK470443/
    Google Scholar
  • 7 Zhao R, Liang H, Clarke E, Jackson C, Xue M. Inflammation in chronic wounds. Int J Mol Sci 2016; 17 (12) E2085
    CrossrefPubMedGoogle Scholar
  • 8 Davis FM, Kimball A, Boniakowski A, Gallagher K. Dysfunctional wound healing in diabetic foot ulcers: new crossroads. Curr Diab Rep 2018; 18 (01) 2
    CrossrefPubMedGoogle Scholar
  • 9 Boniakowski AE, Kimball AS, Jacobs BN, Kunkel SL, Gallagher KA. Macrophage-mediated inflammation in normal and diabetic wound healing. J Immunol 2017; 199 (01) 17-24
    CrossrefPubMedGoogle Scholar
  • 10 Rosique RG, Rosique MJ, Farina Junior JA. Curbing Inflammation in skin wound healing: a review. Int J Inflamm 2015; 2015: 316235
    CrossrefPubMedGoogle Scholar
  • 11 den Dekker A, Davis FM, Kunkel SL, Gallagher KA. Targeting epigenetic mechanisms in diabetic wound healing. Transl Res 2019; 204: 39-50
    CrossrefPubMedGoogle Scholar
  • 12 Mahdavian Delavary B, van der Veer WM, van Egmond M, Niessen FB, Beelen RHJ. Macrophages in skin injury and repair. Immunobiology 2011; 216 (07) 753-762
    CrossrefPubMedGoogle Scholar
  • 13 Boyce DE, Ciampolini J, Ruge F, Murison MS, Harding KG. Inflammatory-cell subpopulations in keloid scars. Br J Plast Surg 2001; 54 (06) 511-516
    CrossrefPubMedGoogle Scholar
  • 14 Mirza RE, Fang MM, Weinheimer-Haus EM, Ennis WJ, Koh TJ. Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice. Diabetes 2014; 63 (03) 1103-1114
    CrossrefPubMedGoogle Scholar
  • 15 Demidova-Rice TN, Durham JT, Herman IM. Wound healing angiogenesis: innovations and challenges in acute and chronic wound healing. Adv Wound Care (New Rochelle) 2012; 1 (01) 17-22
    CrossrefPubMedGoogle Scholar
  • 16 Patel S, Srivastava S, Singh MR, Singh D. Mechanistic insight into diabetic wounds: pathogenesis, molecular targets and treatment strategies to pace wound healing. Biomed Pharmacother 2019; 112: 108615
    CrossrefPubMedGoogle Scholar
  • 17 Greenhalgh DG. Wound healing and diabetes mellitus. Clin Plast Surg 2003; 30 (01) 37-45
    CrossrefPubMedGoogle Scholar
  • 18 Sorg H, Tilkorn DJ, Hager S, Hauser J, Mirastschijski U. Skin wound healing: an update on the current knowledge and concepts. Eur Surg Res 2017; 58 (1-2): 81-94
    CrossrefPubMedGoogle Scholar
  • 19 Minossi JG, Lima Fde O, Caramori CA. et al. Alloxan diabetes alters the tensile strength, morphological and morphometric parameters of abdominal wall healing in rats. Acta Cir Bras 2014; 29 (02) 118-124
    CrossrefPubMedGoogle Scholar
  • 20 Berlanga-Acosta J, Schultz GS, López-Mola E, Guillen-Nieto G, García-Siverio M, Herrera-Martínez L. Glucose toxic effects on granulation tissue productive cells: the diabetics' impaired healing. BioMed Res Int 2013; 2013: 256043
    CrossrefPubMedGoogle Scholar
  • 21 Martin ET, Kaye KS, Knott C. et al. Diabetes and risk of surgical site infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 2016; 37 (01) 88-99
    CrossrefPubMedGoogle Scholar
  • 22 Kantar RS, Rifkin WJ, Wilson SC. et al. Abdominal panniculectomy: determining the impact of diabetes on complications and risk factors for adverse events. Plast Reconstr Surg 2018; 142 (04) 462e-471e
    CrossrefPubMedGoogle Scholar
  • 23 Kao AM, Arnold MR, Augenstein VA, Heniford BT. Prevention and treatment strategies for mesh infection in abdominal wall reconstruction. Plast Reconstr Surg 2018; 142 (3, Suppl): 149S-155S
    CrossrefPubMedGoogle Scholar
  • 24 Chatterjee A, Nahabedian MY, Gabriel A. et al. Early assessment of post-surgical outcomes with pre-pectoral breast reconstruction: a literature review and meta-analysis. J Surg Oncol 2018; 117 (06) 1119-1130
    CrossrefPubMedGoogle Scholar
  • 25 Dortch JD, Eck DL, Ladlie B, TerKonda SP. Perioperative glycemic control in plastic surgery: review and discussion of an institutional protocol. Aesthet Surg J 2016; 36 (07) 821-830
    CrossrefPubMedGoogle Scholar
  • 26 Hanemann Jr MS, Grotting JC. Evaluation of preoperative risk factors and complication rates in cosmetic breast surgery. Ann Plast Surg 2010; 64 (05) 537-540
    CrossrefPubMedGoogle Scholar
  • 27 Bamba R, Gupta V, Shack RB, Grotting JC, Higdon KK. Evaluation of diabetes mellitus as a risk factor for major complications in patients undergoing aesthetic surgery. Aesthet Surg J 2016; 36 (05) 598-608
    CrossrefPubMedGoogle Scholar
  • 28 Lipira AB, Sood RF, Tatman PD, Davis JI, Morrison SD, Ko JH. Complications within 30 days of hand surgery: an analysis of 10,646 patients. J Hand Surg Am 2015; 40 (09) 1852-59.e3
    CrossrefPubMedGoogle Scholar
  • 29 Brown E, Genoway KA. Impact of diabetes on outcomes in hand surgery. J Hand Surg Am 2011; 36 (12) 2067-2072
    CrossrefPubMedGoogle Scholar
  • 30 Federer AE, Baumgartner RE, Cunningham DJ, Mithani SK. Increased rate of complications following trigger finger release in diabetic patients. Plast Reconstr Surg 2020; 146 (04) 420e-427e
    CrossrefPubMedGoogle Scholar
  • 31 Werner BC, Teran VA, Deal DN. Patient-related risk factors for infection following open carpal tunnel release: an analysis of over 450,000 Medicare patients. J Hand Surg Am 2018; 43 (03) 214-219
    CrossrefPubMedGoogle Scholar
  • 32 Raikundalia M, Svider PF, Hanba C. et al. Facial fracture repair and diabetes mellitus: an examination of postoperative complications. Laryngoscope 2017; 127 (04) 809-814
    CrossrefPubMedGoogle Scholar
  • 33 Molnar JA, Vlad LG, Gumus T. Nutrition and chronic wounds: improving clinical outcomes. Plast Reconstr Surg 2016; 138 (3, Suppl): 71S-81S
    CrossrefPubMedGoogle Scholar
  • 34 Zhang S-S, Tang Z-Y, Fang P, Qian H-J, Xu L, Ning G. Nutritional status deteriorates as the severity of diabetic foot ulcers increases and independently associates with prognosis. Exp Ther Med 2013; 5 (01) 215-222
    CrossrefPubMedGoogle Scholar
  • 35 Tatti P, Barber A. The Use of a Specialized nutritional supplement for diabetic foot ulcers reduces the use of antibiotics. J Clin Endocrinol Metab 2012; 2 (01) 26-31
    PubMedGoogle Scholar
  • 36 Abdel-Salam BKA-H. Modulatory effect of whey proteins in some cytokines involved in wound healing in male diabetic albino rats. Inflammation 2014; 37 (05) 1616-1622
    CrossrefPubMedGoogle Scholar
  • 37 Niu Y, Cao X, Song F. et al. Reduced dermis thickness and AGE accumulation in diabetic abdominal skin. Int J Low Extrem Wounds 2012; 11 (03) 224-230
    CrossrefPubMedGoogle Scholar
  • 38 Van Putte L, De Schrijver S, Moortgat P. The effects of advanced glycation end products (AGEs) on dermal wound healing and scar formation: a systematic review. Scars Burn Heal 2016; 2: 2059513116676828
    CrossrefPubMedGoogle Scholar
  • 39 Uribarri J, Woodruff S, Goodman S. et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc 2010; 110 (06) 911-16.e12
    CrossrefPubMedGoogle Scholar
  • 40 Akhtar S, Barash PG, Inzucchi SE. Scientific principles and clinical implications of perioperative glucose regulation and control. Anesth Analg 2010; 110 (02) 478-497
    CrossrefPubMedGoogle Scholar
  • 41 Understanding A1C. American Diabetes Association. Accessed April 28, 2021 at: https://www.diabetes.org/a1c
    PubMedGoogle Scholar
  • 42 Cunningham DJ, Baumgartner RE, Federer AE, Richard MJ, Mithani SK. Elevated preoperative hemoglobin A1c associated with increased wound complications in diabetic patients undergoing primary, open carpal tunnel release. Plast Reconstr Surg 2019; 144 (04) 632e-638e
    CrossrefPubMedGoogle Scholar
  • 43 Dronge AS, Perkal MF, Kancir S, Concato J, Aslan M, Rosenthal RA. Long-term glycemic control and postoperative infectious complications. Arch Surg 2006; 141 (04) 375-380 , discussion 380
    CrossrefPubMedGoogle Scholar
  • 44 Cohen O, Lam G, Choi M, Ceradini D, Karp N. Risk factors for delays in adjuvant chemotherapy following immediate breast reconstruction. Plast Reconstr Surg 2018; 142 (02) 299-305
    CrossrefPubMedGoogle Scholar
  • 45 Walker RJ, Strom Williams J, Egede LE. Influence of race, ethnicity and social determinants of health on diabetes outcomes. Am J Med Sci 2016; 351 (04) 366-373
    CrossrefPubMedGoogle Scholar
  • 46 Goltsman D, Morrison KA, Ascherman JA. Defining the association between diabetes and plastic surgery outcomes: an analysis of nearly 40,000 patients. Plast Reconstr Surg Glob Open 2017; 5 (08) e1461
    CrossrefPubMedGoogle Scholar
  • 47 Abdelhafez AHK, Taha O, Abdelaal M, Al-Najim W, le Roux CW, Docherty NG. Impact of abdominal subcutaneous fat reduction on glycemic control in obese patients with type 2 diabetes mellitus. Bariatr Surg Pract Patient Care 2017; 13 (01) 25-32
    CrossrefPubMedGoogle Scholar
  • 48 Climov M, Bayer LR, Moscoso AV, Matsumine H, Orgill DP. The role of dermal matrices in treating inflammatory and diabetic wounds. Plast Reconstr Surg 2016; 138 (3, Suppl): 148S-157S
    CrossrefPubMedGoogle Scholar
  • 49 Krug E, Berg L, Lee C. et al; International Expert Panel on Negative Pressure Wound Therapy [NPWT-EP]. Evidence-based recommendations for the use of negative pressure wound therapy in traumatic wounds and reconstructive surgery: steps towards an international consensus. Injury 2011; 42 (Suppl. 01) S1-S12
    CrossrefPubMedGoogle Scholar
  • 50 Zhang J, Hu Z-C, Chen D, Guo D, Zhu J-Y, Tang B. Effectiveness and safety of negative-pressure wound therapy for diabetic foot ulcers: a meta-analysis. Plast Reconstr Surg 2014; 134 (01) 141-151
    CrossrefPubMedGoogle Scholar
  • 51 Del Pino-Sedeño T, Trujillo-Martín MM, Andia I. et al. Platelet-rich plasma for the treatment of diabetic foot ulcers: a meta-analysis. Wound Repair Regen 2019; 27 (02) 170-182
    CrossrefPubMedGoogle Scholar
  • 52 Martí-Carvajal AJ, Gluud C, Nicola S. et al. Growth factors for treating diabetic foot ulcers. Cochrane Database Syst Rev 2015; (10) CD008548
    PubMedGoogle Scholar
  • 53 Yamakawa S, Hayashida K. Advances in surgical applications of growth factors for wound healing. Burns Trauma 2019; 7 (01) 10
    CrossrefPubMedGoogle Scholar
  • 54 Regranex (becaplermin) Information. FDA. Published online November 3, 2018. Accessed May 7, 2021 at: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/regranex-becaplermin-information
    PubMedGoogle Scholar
  • 55 Pourmoussa A, Gardner DJ, Johnson MB, Wong AK. An update and review of cell-based wound dressings and their integration into clinical practice. Ann Transl Med 2016; 4 (23) 457
    CrossrefPubMedGoogle Scholar
  • 56 Acellular matrices for the treatment of wounds - Wounds International. Wounds Int.. Published online January 19, 2011. Accessed April 29, 2021 at: https://www.woundsinternational.com/resources/details/acellular-matrices-treatment-wounds
    PubMedGoogle Scholar
  • 57 Spampinato SF, Caruso GI, De Pasquale R, Sortino MA, Merlo S. The treatment of impaired wound healing in diabetes: looking among old drugs. Pharmaceuticals (Basel) 2020; 13 (04) E60
    CrossrefPubMedGoogle Scholar
  • 58 Long M, Cai L, Li W. et al. DPP-4 inhibitors improve diabetic wound healing via direct and indirect promotion of epithelial-mesenchymal transition and reduction of scarring. Diabetes 2018; 67 (03) 518-531
    CrossrefPubMedGoogle Scholar
  • 59 Suwanai H, Watanabe R, Sato M, Odawara M, Matsumura H. Dipeptidyl peptidase-4 inhibitor reduces the risk of developing hypertrophic scars and keloids following median sternotomy in diabetic patients: a nationwide retrospective cohort study using the National Database of Health Insurance Claims of Japan. Plast Reconstr Surg 2020; 146 (01) 83-89
    CrossrefPubMedGoogle Scholar
  • 60 Maranda EL, Rodriguez-Menocal L, Badiavas EV. Role of mesenchymal stem cells in dermal repair in burns and diabetic wounds. Curr Stem Cell Res Ther 2017; 12 (01) 61-70
    CrossrefPubMedGoogle Scholar
  • 61 Liang G, Zhang Y. Genetic and epigenetic variations in iPSCs: potential causes and implications for application. Cell Stem Cell 2013; 13 (02) 149-159
    CrossrefPubMedGoogle Scholar
  • 62 Vig S, Dowsett C, Berg L. et al; International Expert Panel on Negative Pressure Wound Therapy [NPWT-EP]. Evidence-based recommendations for the use of negative pressure wound therapy in chronic wounds: steps towards an international consensus. J Tissue Viability 2011; 20 (Suppl. 01) S1-S18
    CrossrefPubMedGoogle Scholar
  • 63 Baltzis D, Eleftheriadou I, Veves A. Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights. Adv Ther 2014; 31 (08) 817-836
    CrossrefPubMedGoogle Scholar
  • 64 Boulton AJM, Armstrong DG, Kirsner RS. et al. Diagnosis and Management of Diabetic Foot Complications. American Diabetes Association; 2018. DOI: 10.2337/db20182-1
    CrossrefGoogle Scholar
  • 65 Patry J, Blanchette V. Enzymatic debridement with collagenase in wounds and ulcers: a systematic review and meta-analysis. Int Wound J 2017; 14 (06) 1055-1065
    CrossrefPubMedGoogle Scholar
  • 66 Onesti MG, Fioramonti P, Fino P, Sorvillo V, Carella S, Scuderi N. Effect of enzymatic debridement with two different collagenases versus mechanical debridement on chronic hard-to-heal wounds. Int Wound J 2016; 13 (06) 1111-1115
    CrossrefPubMedGoogle Scholar
  • 67 Malone-Povolny MJ, Maloney SE, Schoenfisch MH. Nitric oxide therapy for diabetic wound healing. Adv Healthc Mater 2019; 8 (12) e1801210
    CrossrefPubMedGoogle Scholar
  • 68 Erdoğan A, Düzgün AP, Erdoğan K, Özkan MB, Coşkun F. Efficacy of hyperbaric oxygen therapy in diabetic foot ulcers based on Wagner classification. J Foot Ankle Surg 2018; 57 (06) 1115-1119
    CrossrefPubMedGoogle Scholar
  • 69 Martínez-Jiménez MA, Aguilar-García J, Valdés-Rodríguez R. et al. Local use of insulin in wounds of diabetic patients: higher temperature, fibrosis, and angiogenesis. Plast Reconstr Surg 2013; 132 (06) 1015e-1019e
    CrossrefPubMedGoogle Scholar